Caracterización de la ventilación en la edificación residencial existente. Conciliación entre calidad del aire interior y eficiencia en la rehabilitación energética

La edificación residencial existente en España y en Europa se encuentra abocada a una rehabilitación profunda para cumplir los objetivos marcados en la estrategia europea para el año 2050. Estos, para el sector de la edificación, se proponen una reducción del 90% de emisiones de gases de efecto invernadero (GEI) respecto a niveles del año 1990. Este plan a largo plazo establece hitos intermedios de control, con objetivos parciales para el año 2020 y 2030. El objetivo último es aprovechar el potencial de reducción de demanda energética del sector de la edificación, del cual la edificación residencial supone el 85% en España. Dentro de estos requerimientos, de reducción de demanda energética en la edificación, la ventilación en la edificación residencial se convierte en uno de los retos a resolver por su vinculación directa a la salud y el confort de los ocupantes de la misma, y al mismo tiempo su relación proporcional con la demanda energética que presenta el edificio asociada al acondicionamiento térmico. Gran parte de las pérdidas térmicas de la edificación residencial se producen por el aire de renovación y la infiltración de aire a través de la envolvente. La directiva europea de eficiencia energética de la edificación (EPBD), que establece las directrices necesarias para alcanzar los objetivos de este sector en cuanto a emisiones de CO2 y gases de efecto invernadero (GEI), contempla la ventilación con aire limpio como un requisito fundamental a tener en cuenta de cara a las nuevas construcciones y a la rehabilitación energética de los edificios existentes. El síndrome del edificio enfermo, un conjunto de molestias y síntomas asociados a la baja calidad del aire de edificios no residenciales que surgió a raíz de la crisis del petróleo de 1973, tuvo su origen en una ventilación deficiente y una renovación del aire interior insuficiente de estos edificios, producto del intento de ahorro en la factura energética. Teniendo en cuenta que, de media, pasamos un 58% de nuestro tiempo en las viviendas, es fundamental cuidar la calidad del aire interior y no empeorarla aplicando medidas de “eficiencia energética” con efectos no esperados. Para conseguir esto es fundamental conocer en profundidad cómo se produce la ventilación en la edificación en bloque en España en sus aspectos de calidad del aire interior y demanda energética asociada a la ventilación. El objetivo de esta tesis es establecer una metodología de caracterización y de optimización de las necesidades de ventilación para los espacios residenciales existentes en España que aúne el doble objetivo de garantizar la calidad ambiental y reducir la demanda energética de los mismos. La caracterización del parque edificatorio residencial español en cuanto a ventilación es concluyente: La vivienda en España se distribuye principalmente en tres periodos en los que se encuentran más del 80% del total de las viviendas construidas. El periodo anterior a las normas básicas de la edificación (NBE), de 1960 a 1980, el periodo desde 1980 al año 2005, con el mayor número total de viviendas construidas, guiado por la NTE ISV 75, y el periodo correspondiente a la edificación construida a partir del Código Técnico de la Edificación, en 2006, cuyo documento básico de condiciones de salubridad (DB HS3) es la primera norma de obligado cumplimiento en diseño y dimensionamiento de ventilación residencial en España. La selección de un modelo de bloque de viviendas de referencia, un valor medio y representativo, seleccionado de entre estos periodos, pero con cualidades que se extienden más allá de uno de ellos, nos permite realizar un intensivo análisis comparativo de las condiciones de calidad de aire interior y la demanda energética del mismo, aplicando las distintas configuraciones que presenta la ventilación en viviendas dependiendo del escenario o época constructiva (o normativa) en que esta fuera construida. Este análisis se lleva a cabo apoyándose en un doble enfoque: el modelado numérico de simulaciones y el análisis de datos experimentales, para comprobar y afinar los modelos y observar la situación real de las viviendas en estos dos aspectos. Gracias a las conclusiones del análisis previo, se define una estrategia de optimización de la ventilación basada fundamentalmente en dos medidas: 1) La introducción de un sistema de extracción mecánica y recuperación de calor que permita reducir la demanda energética debida a la renovación del aire y a la vez diluir los contaminantes interiores más eficazmente para mejorar, de esta forma, la calidad del ambiente interior. 2) La racionalización del horario de utilización de estos sistemas, no malgastando la energía en periodos de no ocupación, permitiendo una leve ventilación de fondo, debida a la infiltración, que no incida en pérdidas energéticas cuantiosas. A esta optimización, además de aplicar la metodología de análisis previo, en cuanto a demanda energética y calidad del aire, se aplica una valoración económica integradora y comparativa basada en el reglamento delegado EU244/2012 de coste óptimo (Cost Optimal Methodology). Los resultados principales de esta tesis son: • Un diagnóstico de la calidad del aire interior de la edificación residencial en España y su demanda energética asociada, imprescindible para lograr una rehabilitación energética profunda garantizando la calidad del aire interior. • Un indicador de la relación directa entre calidad de aire y demanda energética, para evaluar la adecuación de los sistemas de ventilación, respecto de las nuevas normativas de eficiencia energética y ventilación. • Una estrategia de optimización, que ofrece una alternativa de intervención, y la aplicación de un método de valoración que permite evaluar la amortización comparada de la instalación de los sistemas. ABSTRACT The housing building stock already built in Spain and Europe faces a deep renovation in the present and near future to accomplish with the objectives agreed in the European strategy for 2050. These objectives, for the building sector, are set in a 90% of Green House Gases (GHG) reduction compared to levels in 1990. This long‐term plan has set milestones to control the correct advance of achievement in 2020 and 2030. The main objective is to take advantage of the great potential to reduce energy demand from the building sector, in which housing represents 85% share in Spain. Among this reduction on building energy demand requirements, ventilation of dwellings becomes one of the challenges to solve as it’s directly connected to the indoor air quality (IAQ) and comfort conditions for the users, as well as proportional to the building energy demand on thermal conditioning. A big share of thermal losses in housing is caused by air renovation and infiltration through the envelope leaks. The European Directive on Building energy performance (EPBD), establishes the roots needed to reach the building sector objectives in terms of CO2 and GHG emissions. This directive sets the ventilation and renovation with clean air of the new and existing buildings as a fundamental requirement. The Sick Building Syndrome (SBS), an aggregation of symptoms and annoys associated to low air quality in non residential buildings, appeared as common after the 1973 oil crisis. It is originated in defective ventilation systems and deficient air renovation rates, as a consequence of trying to lower the energy bill. Accounting that we spend 58% of our time in dwellings, it becomes crucial to look after the indoor air quality and focus in not worsening it by applying “energy efficient” measures, with not expected side effects. To do so, it is primary to research in deep how the ventilation takes place in the housing blocks in Spain, in the aspects related to IAQ and ventilation energy demand. This thesis main objective is to establish a characterization and optimization methodology regarding the ventilation needs for existing housing in Spain, considering the twofold objective of guaranteeing the air quality as reducing the energy demand. The characterization of the existing housing building stock in Spain regarding ventilation is conclusive. More of 80% of the housing stock is distributed in 3 main periods: before the implementation of the firsts regulations on building comfort conditions (Normas Básicas de la Edificación), from 1960 to 1980; the period after the first recommendations on ventilation (NTE ISV 75) for housing were set, around 1980 until 2005 and; the period corresponding to the housing built after the existing mandatory regulation in terms of indoor sanity conditions and ventilation (Spanish Building Code, DB HS3) was set, in 2006. Selecting a representative blueprint of a housing block in Spain, which has medium characteristics not just within the 3 periods mention, but which qualities extent beyond the 3 of them, allows the next step, analyzing. This comparative and intense analyzing phase is focused on the air indoor conditions and the related energy demand, applying different configurations to the ventilation systems according to the different constructive or regulation period in which the building is built. This analysis is also twofold: 1) Numerical modeling with computer simulations and 2) experimental data collection from existing housing in real conditions to check and refine the models to be tested. Thanks to the analyzing phase conclusions, an optimization strategy on the ventilation of the housing stock is set, based on two actions to take: 1) To introduce a mechanical exhaust and intake ventilation system with heat recovery that allows reducing energy demand, as improves the capacity of the system to dilute the pollutant load. This way, the environmental quality is improved. 2) To optimize the schedule of the system use, avoids waste of energy in no occupancy periods, relying ventilation during this time in a light infiltration ventilation, intended not to become large and not causing extra energy losses. Apart from applying the previous analyzing methodology to the optimization strategy, regarding energy demand and air quality, a ROI valorization is performed, based on the cost optimal methodology (delegated regulation EU244/2012). The main results from the thesis are: • To obtain a through diagnose regarding air quality and energy demand for the existing housing stock in Spain, unavoidable to reach a energy deep retrofitting scheme with no air quality worsening. • To obtain a marker to relate air quality and energy demand and evaluate adequateness of ventilation systems, for the new regulations to come. • To establish an optimization strategy to improve both air quality and energy demand, applying a compared valorization methodology to obtain the Return On Investment (ROI).

Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders.

Elevated resting heart rate is associated with greater risk of cardiovascular disease and mortality. In a 2-stage meta-analysis of genome-wide association studies in up to 181,171 individuals, we identified 14 new loci associated with heart rate and confirmed associations with all 7 previously established loci. Experimental downregulation of gene expression in Drosophila melanogaster and Danio rerio identified 20 genes at 11 loci that are relevant for heart rate regulation and highlight a role for genes involved in signal transmission, embryonic cardiac development and the pathophysiology of dilated cardiomyopathy, congenital heart failure and/or sudden cardiac death. In addition, genetic susceptibility to increased heart rate is associated with altered cardiac conduction and reduced risk of sick sinus syndrome, and both heart rate-increasing and heart rate-decreasing variants associate with risk of atrial fibrillation. Our findings provide fresh insights into the mechanisms regulating heart rate and identify new therapeutic targets.

Suplementación de hormona tiroidea en pacientes pediátricos críticos con síndrome eutiroideo enfermo

Introducción : el síndrome del eutiriodeo enfermo en enfermedades graves es factor de pobre pronóstico. La suplementación con hormona tiroidea mejora la contractibilidad miocardica y estimula la producción de surfactante pulmonar; sin embargo existe controversia debido a las complicaciones secundarias, ausencia de efectos a nivel hemodinámico y de estancia hospitalaria. Objetivo : determinar el efecto de la suplementación oral de hormonas tiroideas en pacientes con choque refractario y necesidad de más de dos inotrópicos con respecto a estabilidad hemodinámica, arritmias, requerimientos de inotrópicos y mortalidad asociada al tratamiento. Metodología : estudio longitudinal observacional de variables repetidas con análisis previo y posterior a la intervención. Realizado en pacientes con choque refractario de la unidad de cuidado intensivo pediátrico del Hospital Simón Bolívar, desde el 1 de enero del 2007 hasta 1 enero del 2009. Resultados: la suplementación tiroidea mostró una disminución significativa en el requerimiento de los inotrópicos adrenérgicos: dopamina, adrenalina y noradrenalina con rangos de [4,78-2.4], [3.92 - 2.98] y [3.58- 2.24] (p <0.001) respectivamente, sin haber diferencia en los vasodilatadores, inodilatadores y diuréticos. No se encontró asociación entre su uso y la presencia de arritmias. Discusión y conclusiones: La hormona tiroidea mostró efecto benéfico en términos de disminución de soporte inotrópico. resultado en concordancia con la literatura y relacionado con la función moduladora de la hormona tiroidea favoreciendo la inotropía miocardica y los índices de contractilidad ventricular izquierda.

Ivabradine: Just another New Pharmacological Option for Heart Rate Control?

Ivabradine (IVB) is a heart rate lowering agent that acts via selective inhibition of the pacemaker funny current in sinoatrial nodal P cells, thus, reducing heart rate at rest and during exercise with minimal effect on myocardial contractility, blood pressure, and intracardiac conduction. IVB exerts no effect on external respiratory function parameters and it may also play a role in patients with concurrent chronic obstructive pulmonary disease. This property constitutes an important advantage over β-blockers. IVB acts by reducing the heart rate in a mechanism different from β-blockers, calcium channel blockers or late sodium channel blockers, three commonly prescribed antianginal drugs. As clinical trials have shown, it is remarkably well-tolerated and offers an alternative for patients who cannot take β-blockers. The combination of IVB and atenolol at commonly used doses in patients with chronic stable angina produced additional efficacy with no untoward effect on safety or tolerability. Additionally, side effects are rare and largely limited to a luminous phenomenon or phosphenes. This sensation is thought to be due to a block of Ih in the retina, a current very similar to cardiac If channels. IVB is contraindicated in patients with sick sinus syndrome or sinus node dysfunction and in patients taking hepatic inhibitors of Cytochrome P450 family 3, subfamily A, polypeptide 4 (abbreviated CYP3A4), with exception of omeprazole or lansoprazole. This review briefly summarizes the main studies regarding this drug.

Cardiac sodium channel Na(v)1.5 and interacting proteins: Physiology and pathophysiology

The cardiac voltage-gated Na(+) channel Na(v)1.5 generates the cardiac Na(+) current (INa). Mutations in SCN5A, the gene encoding Na(v)1.5, have been linked to many cardiac phenotypes, including the congenital and acquired long QT syndrome, Brugada syndrome, conduction slowing, sick sinus syndrome, atrial fibrillation, and dilated cardiomyopathy. The mutations in SCN5A define a sub-group of Na(v)1.5/SCN5A-related phenotypes among cardiac genetic channelopathies. Several research groups have proposed that Na(v)1.5 may be part of multi-protein complexes composed of Na(v)1.5-interacting proteins which regulate channel expression and function. The genes encoding these regulatory proteins have also been found to be mutated in patients with inherited forms of cardiac arrhythmias. The proteins that associate with Na(v)1.5 may be classified as (1) anchoring/adaptor proteins, (2) enzymes interacting with and modifying the channel, and (3) proteins modulating the biophysical properties of Na(v)1.5 upon binding. The aim of this article is to review these Na(v)1.5 partner proteins and to discuss how they may regulate the channel's biology and function. These recent investigations have revealed that the expression level, cellular localization, and activity of Na(v)1.5 are finely regulated by complex molecular and cellular mechanisms that we are only beginning to understand.

Cardiac sodium channel NaV1.5 distribution in myocytes via interacting proteins: the multiple pool model

The cardiac sodium current (INa) is responsible for the rapid depolarization of cardiac cells, thus allowing for their contraction. It is also involved in regulating the duration of the cardiac action potential (AP) and propagation of the impulse throughout the myocardium. Cardiac INa is generated by the voltage-gated Na(+) channel, NaV1.5, a 2016-residue protein which forms the pore of the channel. Over the past years, hundreds of mutations in SCN5A, the human gene coding for NaV1.5, have been linked to many cardiac electrical disorders, including the congenital and acquired long QT syndrome, Brugada syndrome, conduction slowing, sick sinus syndrome, atrial fibrillation, and dilated cardiomyopathy. Similar to many membrane proteins, NaV1.5 has been found to be regulated by several interacting proteins. In some cases, these different proteins, which reside in distinct membrane compartments (i.e. lateral membrane vs. intercalated disks), have been shown to interact with the same regulatory domain of NaV1.5, thus suggesting that several pools of NaV1.5 channels may co-exist in cardiac cells. The aim of this review article is to summarize the recent works that demonstrate its interaction with regulatory proteins and illustrate the model that the sodium channel NaV1.5 resides in distinct and different pools in cardiac cells. This article is part of a Special Issue entitled: Cardiomyocyte Biology: Cardiac Pathways of Differentiation, Metabolism and Contraction.

Microbiological assessment of indoor air quality at different hospital sites

Poor hospital indoor air quality (IAQ) may lead to hospital-acquired infections, sick hospital syndrome and various occupational hazards. Air-control measures are crucial for reducing dissemination of airborne biological particles in hospitals. The objective of this study was to perform a survey of bioaerosol quality in different sites in a Portuguese Hospital, namely the operating theater (OT), the emergency service (ES) and the surgical ward (SW). Aerobic mesophilic bacterial counts (BCs) and fungal load (FL) were assessed by impaction directly onto tryptic soy agar and malt extract agar supplemented with antibiotic chloramphenicol (0.05%) plates, respectively using a MAS-100 air sampler. The ES revealed the highest airborne microbial concentrations (BC range 240-736 CFU/m(3) CFU/m(3); FL range 27-933 CFU/m(3)), exceeding, at several sampling sites, conformity criteria defined in national legislation [6]. Bacterial concentrations in the SW (BC range 99-495 CFU/m(3)) and the OT (BC range 12-170 CFU/m(3)) were under recommended criteria. While fungal levels were below 1 CFU/m(3) in the OT, in the SW (range 1-32 CFU/m(3)), there existed a site with fungal indoor concentrations higher than those detected outdoors. Airborne Gram-positive cocci were the most frequent phenotype (88%) detected from the measured bacterial population in all indoor environments. Staphylococcus (51%) and Micrococcus (37%) were dominant among the bacterial genera identified in the present study. Concerning indoor fungal characterization, the prevalent genera were Penicillium (41%) and Aspergillus (24%). Regular monitoring is essential for assessing air control efficiency and for detecting irregular introduction of airborne particles via clothing of visitors and medical staff or carriage by personal and medical materials. Furthermore, microbiological survey data should be used to clearly define specific air quality guidelines for controlled environments in hospital settings.

Thyroid function in multidrug-resistant tuberculosis patients with or without human immunodeficiency virus (HIV) infection before commencement of MDR-TB drug regimen.

Background: Mycobacterium tuberculosis and human immunodeficiency virus (HIV) are known to cause abnormal thyroid function. There is little information on whether HIV infection aggravates alteration of thyroid function in patients with MDRTB. Objectives: This study was carried out to determine if HIV co-infection alters serum levels of thyroid hormones (T3, T4) and thyroid stimulating hormone (TSH) in patients with MDR-TB patients and to find out the frequency of subclinical thyroid dysfunction before the commencement of MDR-TB therapy. Methods: This observational and cross-sectional study involved all the newly admitted patients in MDR-TB Referral Centre, University College Hospital, Ibadan, Nigeria between July 2010 and December 2014. Serum levels of thyroid stimulating hormone (TSH), free thyroxine (fT4) and free triiodothyronine (fT3) were determined using ELISA. Results: Enrolled were 115 patients with MDR-TB, out of which 22 (19.13%) had MDR-TB/HIV co-infection. Sick euthyroid syndrome (SES), subclinical hypothyroidism and subclinical hyperthyroidism were observed in 5 (4.35%), 9 (7.83%) and 2 (1.74%) patients respectively. The median level of TSH was insignificantly higher while the median levels of T3 and T4 were insignificantly lower in patients with MDR-TB/HIV co-infection compared with patients with MDRT-TB only. Conclusion: It could be concluded from this study that patients with MDR-TB/HIV co-infection have a similar thyroid function as patients having MDR-TB without HIV infection before commencement of MDR-TB drug regimen. Also, there is a possibility of subclinical thyroid dysfunction in patients with MDR-TB/HIV co-infection even, before the commencement of MDR-TB therapy.

A gene variation (rs12691) in the CCAT/enhancer building α modulates glucose metabolism in metabolic syndrome

Background and aims CCAAT/enhancer-binding protein alpha (CEBPA) is a transcription factor involved in adipogenesis and energy homeostasis. Caloric restriction reduces CEBPA protein expression in patients with metabolic syndrome (MetS). A previous report linked rs12691 SNP in CEBPA to altered concentration of fasting triglycerides. Our objective was to assess the effects of rs12691 in glucose metabolism in Metabolic Syndrome (MetS) patients. Methods and results Glucose metabolism was assessed by static (glucose, insulin, adiponectin, leptin and resistin plasma concentrations) and dynamic (disposition index, insulin sensitivity index, HOMA-IR and acute insulin response to glucose) indices, performed at baseline and after 12 weeks of 4 dietary interventions (high saturated fatty acid (SFA), high monounsaturated fatty acid (MUFA), low-fat and low-fat-high-n3 polyunsaturated fatty acid (PUFA)) in 486 subjects with MetS. Carriers of the minor A allele of rs12691 had altered disposition index (p = 0.0003), lower acute insulin response (p = 0.005) and a lower insulin sensitivity index (p = 0.025) indicating a lower insulin sensitivity and a lower insulin secretion, at baseline and at the end of the diets. Furthermore, A allele carriers displayed lower HDL concentration. Conclusion The presence of the A allele of rs12691 influences glucose metabolism of MetS patients. Clinical Trials Registry number NCT00429195.

Be fit or be sick: peroxisome proliferator-activated receptors are down the road.

Investigating metabolism by unveiling the functions of the nuclear receptors peroxisome proliferator-activated receptors (PPARs) in the numerous intricate pathways ensuring energy homeostasis and fitness has been extremely rewarding. Major lines of research were initially determined by the first-characterized crucial roles of PPARalpha in fatty oxidation and of PPARgamma in adipocyte differentiation and lipid storage. Today, the molecular bases of the functional links between glucose, lipid, and protein metabolism, under the important but nonexclusive control of PPARalpha and PPARgamma, are starting to be uncovered. In addition, in the last couple of years evidence has been provided for an important role of PPARbeta (delta) in lipid metabolism. Inevitably, such actors of metabolic homeostasis are implicated in the physiopathology of complex metabolic disorders, such as those constituting the metabolic syndrome, resulting in atherosclerosis and cardiovascular diseases. This review presents a summary of the recent findings on their dual involvement in health and disease.

Intratracheal suctioning in sick preterm infants: prevention of intracranial hypertension and cerebral hypoperfusion by muscle paralysis.

In a prospective nonrandomized study, using each baby as his or her own control, we compared intracranial pressure (anterior fontanel pressure as measured with the Digilab pneumotonometer), cerebral perfusion pressure, BP, heart rate, transcutaneous Po2, and transcutaneous Pco2 before, during, and after endotracheal suctioning, with and without muscle paralysis, in 28 critically ill preterm infants with respiratory distress syndrome. With suctioning, there was a small but significant increase in intracranial pressure in paralyzed patients (from 13.7 [mean] +/- 4.4 mm Hg [SD] to 15.8 +/- 5.2 mm Hg) but a significantly larger (P less than .001) increase when they were not paralyzed (from 12.5 +/- 3.6 to 28.5 +/- 8.3 mm Hg). Suctioning led to a slight increase in BP with (from 45.3 +/- 9.1 to 48.0 +/- 8.7 mm Hg) and without muscle paralysis (from 45.1 +/- 9.4 to 50.0 +/- 11.7 mm Hg); but there was no significant difference between the two groups. The cerebral perfusion pressure in paralyzed infants did not show any significant change before, during, and after suctioning (31.5 +/- 9.1 mm Hg before v 32.0 +/- 8.7 mm Hg during suctioning), but without muscle paralysis cerebral perfusion pressure decreased (P less than .001) from 32.8 +/- 9.7 to 21.3 +/- 13.1 mm Hg. Suctioning induced a slight decrease in mean heart rate and transcutaneous Po2, but pancuronium did not alter these changes. There was no statistical difference in transcutaneous Pco2 before, during, and after suctioning with and without muscle paralysis.(ABSTRACT TRUNCATED AT 250 WORDS)

Modified 'Stent-Graft Sandwich' Technique for Treatment of Isolated Common Iliac Artery Aneurysm in Patient With Marfan Syndrome

Isolated iliac artery aneurysms are rare in the general population (0.03%) and represent 2% of all abdominal aneurysms, and the association with Marfan syndrome is even rarer. We report a Marfan syndrome case with an isolated common iliac artery aneurysm treated by using a modified 'stent-graft sandwich' technique, with preservation of the internal iliac artery perfusion. The modified 'stent-graft sandwich' technique involves building an appropriate proximal neck just in the common iliac artery for fittingly housing two new stent-grafts inside, both deployed simultaneously and each one going to both distal iliac arteries (internal and external).

[Tremorgenic syndrome in a cattle herd after feeding silage contaminated with A. clavatus];;Tremorgenes Syndrom in einem Rinderbestand nach Verfütterung einer mit A. clavatus befallenen Silage

The clinical signs, pathological and laboratory findings of cattle suffering from a tremorgenic syndrome are described. Animals on a farm with a total of 22 cows, 18 heifers and 9 calves were fed mouldy grass and spent malt-grain silage. Five heifers were affected with muscular tremor, hyperexcitability and hypersensitivity. They were ataxic or in sternal recumbency, while their appetite remained normal. Haematology and blood chemistry in two heifers as well as cerebrospinal fluid from one sick animal were unremarkable. The pathological examination of one animal brought no macroscopic changes to light. Histological examination, however, revealed the degeneration of motor neurones in the midbrain, brain stem and spinal cord. Analysis of a silage sample provided evidence of the presence of Aspergillus clavatus, a mould capable of producing neurotoxic tremorgenic mycotoxins. Epidemiology, clinical findings, pathology and microbiological examination suggest that the five cattle were suffering from neuromycotoxicosis.

Intra-colonial response to Acroporid "White syndrome" lesions in tabular Acropora spp. (Scleractinia)

'White syndrome' is considered to be the most prevalent coral disease on the Great Barrier Reef, characterised by rapid rates of lesion progression and high levels of colony mortality. This study investigated the production and translocation of photoassimilates towards white syndrome lesions (WSLs) and artificially inflicted lesions in healthy and diseased colonies of tabular Acropora spp. to determine the intra-colonial response to white syndrome using C-14 labelling. Translocation of C-14 labelled photoassimilates was preferentially orientated away from active WSLs, with minimal C-14 activity observed in the lesion borders, whilst artificial lesions (ALs) created directly opposite WSL borders showed significantly higher C-14 activity, suggesting active translocation of photoassimilates for tissue regeneration. Transport of photoassimilates in healthy coral colonies was preferentially oriented towards ALs with a higher perimeter-area ratio, although translocation towards WSL boundaries was minimal even though the lesion perimeter was often the width of the colony (> 200 cm). We suggest that the preferential orientation of photoassimilates away from WSLs may represent a deliberate strategy by the colony to induce a 'shutdown reaction' in order to preserve intra-colonial resources within areas of the colony that are more likely to survive and recover.